Combined analysis from two large studies verified that the noninvasive tools Fibrosis-4 index, aspartate aminotransferase-to-platelet ratio, and NAFLD fibrosis score were able to detect advanced fibrosis and fibrosis progression in patients with nonalcoholic fatty liver disease.
“Although major international consortia are currently engaged in efforts to qualify noninvasive measures of disease assessment in NAFLD, they are still years away from fruition,” Mohammad S. Siddiqui, MD, from the Virginia Commonwealth University, and colleagues wrote. “There is therefore an unmet

Source link